ATI RN
Hematologic drugs Questions
Question 1 of 5
If a patient is taking darbepoetin alfa (Aranesp), their blood counts should be monitored to determine if a dosage adjustment is needed. How soon should this be done after starting the drug?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 2 of 5
Patients who are beginning therapy with vitamin B12 need to be monitored for:
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 3 of 5
Which of the following is not associated with thrombotic thrombocytopenic purpura?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 4 of 5
Which of the following requires IL-2 and IL-4 in the conversion of unilineage progenitor cell into mature circulating cell?
Correct Answer: D
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 5 of 5
Which of the following is not a good prognostic factor in patient with acute lymphoblastic leukemia?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.